ZUBERITAMAB
UNII P1DFX74SQ8

Substance Identification & Data

This profile provides standardized clinical and technical data for Zuberitamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) P1DFX74SQ8.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2251143-19-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

P1DFX74SQ8

CAS Registry Number

2251143-19-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ZUBERITAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C174825

National Cancer Institute reference terminology for clinical and research data.

INN ID

11331

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zuberitamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZUBERITAMAB

Common Names & Synonyms

GAMMA1 HEAVY CHAIN CHIMERIC (1-452) (VH (MUS MUSCULUS IGHV1-12*01(96.9%)-(IGHD)-IGHJ1*03 (100%)/HOMO SAPIENS IGHV1-46*01 (70.4%)-(IGHD)-IGHJ1*03 (85.7%)) (8.8.15) (1-122)-HOMO SAPIENSIGHG1*01 (100%) G1M17,1 (CH1 K120 (219) (123-220), HINGE 1-15 (221-235), CH2 (236-345), CH3 D12 (361), L14 (363) (346-450), CHS (451-452)) (123-452)), (225-213')-DISULFIDE WITH KAPPA LIGHT CHAIN CHIMERIC (1'-213') (V-KAPPA (MUS MUSCULUS IGKV4-72*01 (96.8%)-IGKJ1*01 (90.9 %)/HOMO SAPIENSIGKV3-11*01 (64.9%)-IGKJ2*01 (90.9%)) (5.3.9) (1'-106')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (152), V101 (190) (107'-213'))DIMER (231-231'':234-234'')-BISDISULFIDE

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL HS006 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HS006 .KAPPA.-CHAIN, DIMER

ZUBERITAMAB [INN]

ZUBERITAMAB [WHO-DD]